1. Cover Image. Issue 3 (22nd July 2020) Authors: Lachaux, Marianne; Soulié, Matthieu; Hamzaoui, Mouad; Bailly, Anaëlle; Nicol, Lionel; Rémy‐Jouet, Isabelle; Renet, Sylvanie; Vendeville, Cathy; Gluais‐Dagorn, Pascale; Hallakou‐Bozec, Sophie; Monteil, Christelle; Richard, Vincent; Mulder, Paul Journal: Endocrinology, diabetes & metabolism Issue: Volume 3:Issue 3(2020) Page Start: i Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Deuterium‐Stabilized (R)‐Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ Activity. Issue 8 (10th April 2021) Authors: Jacques, Vincent; Bolze, Sébastien; Hallakou‐Bozec, Sophie; Czarnik, Anthony W.; Divakaruni, Ajit S.; Fouqueray, Pascale; Murphy, Anne N.; Van der Ploeg, Lex H.T.; DeWitt, Sheila Journal: Hepatology communications Issue: Volume 5:Issue 8(2021) Page Start: 1412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis. Issue 1 (7th September 2021) Authors: Gluais‐Dagorn, Pascale; Foretz, Marc; Steinberg, Gregory R.; Batchuluun, Battsetseg; Zawistowska‐Deniziak, Anna; Lambooij, Joost M.; Guigas, Bruno; Carling, David; Monternier, Pierre‐Axel; Moller, David E.; Bolze, Sebastien; Hallakou‐Bozec, Sophie Journal: Hepatology communications Issue: Volume 6:Issue 1(2022) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Imeglimin preserves islet β‐cell mass in Type 2 diabetic ZDF rats. Issue 2 (7th November 2020) Authors: Hallakou‐Bozec, Sophie; Kergoat, Micheline; Moller, David E.; Bolze, Sébastien Journal: Endocrinology, diabetes & metabolism Issue: Volume 4:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes. Issue 3 (29th December 2020) Authors: Hallakou‐Bozec, Sophie; Vial, Guillaume; Kergoat, Micheline; Fouqueray, Pascale; Bolze, Sébastien; Borel, Anne‐Laure; Fontaine, Eric; Moller, David E. Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 3(2021) Page Start: 664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity. Issue 6 (14th October 2022) Authors: Theurey, Pierre; Thang, Carole; Pirags, Valdis; Mari, Andrea; Pacini, Giovanni; Bolze, Sébastien; Hallakou‐Bozec, Sophie; Fouqueray, Pascale Journal: Endocrinology, diabetes & metabolism Issue: Volume 5:Issue 6(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin. Issue 5 (11th March 2022) Authors: Theurey, Pierre; Vial, Guillaume; Fontaine, Eric; Monternier, Pierre‐Axel; Fouqueray, Pascale; Bolze, Sébastien; Moller, David E.; Hallakou‐Bozec, Sophie Journal: Physiological reports Issue: Volume 10:Issue 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Short‐and long‐term administration of imeglimin counters cardiorenal dysfunction in a rat model of metabolic syndrome. Issue 3 (16th April 2020) Authors: Lachaux, Marianne; Soulié, Matthieu; Hamzaoui, Mouad; Bailly, Anaëlle; Nicol, Lionel; Rémy‐Jouet, Isabelle; Renet, Sylvanie; Vendeville, Cathy; Gluais‐Dagorn, Pascale; Hallakou‐Bozec, Sophie; Monteil, Christelle; Richard, Vincent; Mulder, Paul Journal: Endocrinology, diabetes & metabolism Issue: Volume 3:Issue 3(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells. Issue 2 (23rd February 2021) Authors: Vial, Guillaume; Lamarche, Frédéric; Cottet‐Rousselle, Cécile; Hallakou‐Bozec, Sophie; Borel, Anne‐Laure; Fontaine, Eric Journal: Endocrinology, diabetes & metabolism Issue: Volume 4:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Therapeutic potential of deuterium‐stabilized (R)‐pioglitazone—PXL065—for X‐linked adrenoleukodystrophy. Issue 4 (19th May 2022) Authors: Monternier, Pierre‐Axel; Singh, Jaspreet; Parasar, Parveen; Theurey, Pierre; DeWitt, Sheila; Jacques, Vincent; Klett, Eric; Kaur, Navtej; Nagaraja, Tavarekere N.; Moller, David E.; Hallakou‐Bozec, Sophie Journal: Journal of inherited metabolic disease Issue: Volume 45:Issue 4(2022) Page Start: 832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗